Senior Management

Our management team consists of both industrial and academic scientists with decades of cumulative experience working on insoluble or poorly bioavailable compounds. This translates into an expert understanding of the real requirements of preclinical and clinical development, as well as cGMP and the importance of regulatory acceptability of excipients and manufacturing processes.

Key Staff

Professor Graham Buckton - CEO & Founder

Dr Chris Kirby - Director of Formulation Development

Dr Mark Hooper - Director of Business Development

Dr Stephen Watt - Director of Screening

Mridul Majumder -  Director of Physical Properties